Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
- PMID: 28597400
- PMCID: PMC5509774
- DOI: 10.1007/s00404-017-4420-y
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
Abstract
Purpose: The growing popularity and acceptance of integrative medicine is evident both among patients and among the oncologists treating them. As little data are available regarding health-care professionals' knowledge, attitudes, and practices relating to the topic, a nationwide online survey was designed.
Methods: Over a period of 11 weeks (from July 15 to September 30, 2014) a self-administered, 17-item online survey was sent to all 676 members of the Research Group on Gynecological Oncology (Arbeitsgemeinschaft Gynäkologische Onkologie) in the German Cancer Society. The questionnaire items addressed the use of integrative therapy methods, fields of indications for them, advice services provided, level of specific qualifications, and other topics.
Results: Of the 104 respondents (15.4%) using integrative medicine, 93% reported that integrative therapy was offered to breast cancer patients. The second most frequent type of tumor in connection with which integrative therapy methods were recommended was ovarian cancer, at 80% of the participants using integrative medicine. Exercise, nutritional therapy, dietary supplements, herbal medicines, and acupuncture were the methods the patients were most commonly advised to use.
Conclusion: There is considerable interest in integrative medicine among gynecological oncologists, but integrative therapy approaches are at present poorly implemented in routine clinical work. Furthermore there is a lack of specific training. Whether future efforts should focus on extending counseling services on integrative medicine approaches in gynecologic oncology or not, have to be discussed. Evidence-based training on integrative medicine should be implemented in order to safely guide patients in their wish to do something by themselves.
Keywords: Breast cancer; Complementary medicine; Gynecologic oncology; Integrative medicine; Oncologists’ attitudes; Survey.
Conflict of interest statement
Conflict of interest
None of the authors reported any conflicts of interest.
Ethical approval
All procedures performed in the survey involving human participants were in accordance with the ethical standards of institutional and national research committee. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the survey.
Figures



Similar articles
-
Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany.Arch Gynecol Obstet. 2021 Apr;303(4):967-980. doi: 10.1007/s00404-020-05869-9. Epub 2020 Nov 17. Arch Gynecol Obstet. 2021. PMID: 33201377 Free PMC article.
-
Complementary medicine in radiation oncology : German health care professionals' current qualifications and therapeutic methods.Strahlenther Onkol. 2018 Oct;194(10):904-910. doi: 10.1007/s00066-018-1345-8. Epub 2018 Aug 2. Strahlenther Onkol. 2018. PMID: 30073483 English.
-
Evaluation of an Expert Guided Integrative Therapy Concept in Patients With Breast or Gynecological Cancer During Systemic Therapy.J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20949444. doi: 10.1177/2515690X20949444. J Evid Based Integr Med. 2020. PMID: 32808558 Free PMC article.
-
Integrative Medicine for Female Patients with Gynecologic Cancer.J Altern Complement Med. 2018 Sep/Oct;24(9-10):881-889. doi: 10.1089/acm.2018.0163. J Altern Complement Med. 2018. PMID: 30247969 Review.
-
Integrative Medicine for Ovarian Cancer.Curr Oncol Rep. 2023 Jun;25(6):559-568. doi: 10.1007/s11912-023-01359-8. Epub 2023 Mar 20. Curr Oncol Rep. 2023. PMID: 36939963 Review.
Cited by
-
Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone - efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment.Ger Med Sci. 2022 Jul 14;20:Doc10. doi: 10.3205/000312. eCollection 2022. Ger Med Sci. 2022. PMID: 36160875 Free PMC article. Review.
-
Do Oncologists Recommend the "Pill" of Physical Activity in Their Practice? Answers from the Oncologist and Patients' Perspectives.Cancers (Basel). 2024 Apr 28;16(9):1720. doi: 10.3390/cancers16091720. Cancers (Basel). 2024. PMID: 38730668 Free PMC article.
-
Do Palliative Care Providers Use Complementary and Integrative Medicine? A Nationwide Survey.J Pain Symptom Manage. 2022 Apr;63(4):599-609. doi: 10.1016/j.jpainsymman.2021.11.002. Epub 2021 Nov 14. J Pain Symptom Manage. 2022. PMID: 34788656 Free PMC article.
-
Impact of risk and lifestyle factors on therapy goals in the treatment of breast cancer and gynecological cancer patients with integrative medicine.Arch Gynecol Obstet. 2025 Jun;311(6):1683-1695. doi: 10.1007/s00404-025-08002-w. Epub 2025 Apr 9. Arch Gynecol Obstet. 2025. PMID: 40204922 Free PMC article.
-
Supportive Infusions in Integrative Breast and Gynecological Oncology - Report on Patients' Satisfaction and Self-reported Effects and Side Effects.Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1129-1137. doi: 10.1055/a-0754-2923. Epub 2018 Nov 26. Geburtshilfe Frauenheilkd. 2018. PMID: 30498280 Free PMC article.
References
-
- Münstedt K, Kirsch K, Milch W, et al. Unconventional cancer therapy—survey of patients with gynaecological malignancy. Arch Gynecol Obstet. 1996;258(2):81–88. - PubMed
-
- Kreienberg R, Office des Leitlinienprogramms Onkologie . Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms: Langversion 3.0, Aktualisierung 2012, AWMF-Register-Nummer: 032-045OL. Germering/Munich: Zuckschwerdt; 2012.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials